Samuel Pan

828 total citations
41 papers, 552 citations indexed

About

Samuel Pan is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Samuel Pan has authored 41 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Samuel Pan's work include Advanced Radiotherapy Techniques (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Radiation Therapy and Dosimetry (5 papers). Samuel Pan is often cited by papers focused on Advanced Radiotherapy Techniques (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Radiation Therapy and Dosimetry (5 papers). Samuel Pan collaborates with scholars based in United States, United Kingdom and China. Samuel Pan's co-authors include Nathan Bossa, Chien‐Kuang Cornelia Ding, Bernard Mathey-Prévôt, Po‐Han Chen, Chao‐Chieh Lin, Yitong Xu, Wen‐Hsuan Yang, Jianli Wu, Jen‐Tsan Chi and Divaya Bhutani and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

Samuel Pan

33 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samuel Pan United States 12 298 273 139 101 71 41 552
Jacob E. Berchuck United States 12 248 0.8× 225 0.8× 142 1.0× 124 1.2× 69 1.0× 39 544
Raffaele Cozza Italy 15 215 0.7× 154 0.6× 106 0.8× 115 1.1× 25 0.4× 38 551
Kwai Han Yoo South Korea 15 183 0.6× 210 0.8× 83 0.6× 270 2.7× 85 1.2× 50 588
Deanna Mitchell United States 13 166 0.6× 145 0.5× 77 0.6× 132 1.3× 39 0.5× 20 786
Lijun Zhang China 12 179 0.6× 155 0.6× 70 0.5× 132 1.3× 19 0.3× 36 575
Virginia Fisher United States 13 123 0.4× 182 0.7× 122 0.9× 172 1.7× 137 1.9× 26 571
Hamid Mirshahidi United States 12 164 0.6× 212 0.8× 134 1.0× 291 2.9× 24 0.3× 43 609
Vasilios Panagopoulos Australia 16 166 0.6× 190 0.7× 94 0.7× 137 1.4× 71 1.0× 31 591
Jean Philippe Spano France 11 156 0.5× 363 1.3× 220 1.6× 418 4.1× 26 0.4× 16 815
Farzin Khosrow‐Khavar Canada 11 84 0.3× 171 0.6× 54 0.4× 248 2.5× 63 0.9× 37 730

Countries citing papers authored by Samuel Pan

Since Specialization
Citations

This map shows the geographic impact of Samuel Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Pan more than expected).

Fields of papers citing papers by Samuel Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Pan. The network helps show where Samuel Pan may publish in the future.

Co-authorship network of co-authors of Samuel Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Pan. A scholar is included among the top collaborators of Samuel Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Pan. Samuel Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Pan, Samuel, et al.. (2025). Dual function of Gasdermin E: pyroptosis-mediated pan-cancer suppression versus HCC-specific oncogenic activity. Frontiers in Immunology. 16. 1626311–1626311.
4.
Wynne, Jacob, Yang Lei, Samuel Pan, et al.. (2023). Rapid Unpaired CBCT-Based Synthetic CT for CBCT-Guided Adaptive Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 117(2). S179–S179. 1 indexed citations
5.
Crellin, A., Daniel J. Indelicato, K.J. Kirkby, et al.. (2023). Equity of Access to Proton Beam Therapy in England: A National NHS analysis. International Journal of Radiation Oncology*Biology*Physics. 117(2). e19–e19.
6.
Aznar, Marianne, N.G. Burnet, A. Crellin, et al.. (2023). Assessing Equity of Access to Proton Beam Therapy: A Literature Review. Clinical Oncology. 35(9). e528–e536. 17 indexed citations
7.
Kukafka, Rita, et al.. (2023). Cognitive and emotional factors related to COVID-19 among high-risk ethnically diverse adults at the onset of the New York City outbreak: A cross-sectional survey. Humanities and Social Sciences Communications. 10(1). 245–245. 1 indexed citations
8.
Davey, A., Eliana Vásquez Osorio, A. Datta, et al.. (2023). OC-0777 Automated analysis of internal facial asymmetry on MRI in children. Radiotherapy and Oncology. 182. S645–S647.
9.
Burnet, N.G., Marianne Aznar, Giulia Marvaso, et al.. (2023). Proton Beam Therapy in the Reirradiation Setting of Brain and Base of Skull Tumour Recurrences. Clinical Oncology. 35(10). 673–681. 5 indexed citations
10.
Burnet, N.G., Marianne Aznar, A. Crellin, et al.. (2022). Normal Tissue Complication Probability Modelling for Toxicity Prediction and Patient Selection in Proton Beam Therapy to the Central Nervous System: A Literature Review. Clinical Oncology. 34(6). e225–e237. 12 indexed citations
11.
Lentzsch, Suzanne, Samuel Pan, Divaya Bhutani, et al.. (2021). Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis. Blood Cancer Journal. 11(1). 10–10. 70 indexed citations
12.
Slevin, Finbar, Samuel Pan, Hitesh Mistry, et al.. (2021). A Multicentre UK Study of Outcomes for Locally Advanced Sinonasal Squamous Cell Carcinoma Treated with Adjuvant or Definitive Intensity-modulated Radiotherapy. Clinical Oncology. 33(10). e450–e461. 9 indexed citations
13.
Pan, Samuel, et al.. (2021). Lymphogranuloma Venereum Mimicking Locally Metastatic Rectal Cancer in an HIV-Negative Man. Cureus. 13(12). e20216–e20216. 1 indexed citations
14.
Lentzsch, Suzanne, Raymond L. Comenzo, Jeffrey A. Zonder, et al.. (2020). Bendamustine With Dexamethasone in Relapsed/Refractory Systemic Light-Chain Amyloidosis: Results of a Phase II Study. Journal of Clinical Oncology. 38(13). 1455–1462. 35 indexed citations
15.
Pan, Samuel, J. Belderbos, Ahmed Salem, et al.. (2020). Impact of Peer Review in Reducing Uncertainty in the Definition of the Lung Target Volume Among Trainee Oncologists. Clinical Oncology. 32(6). 363–372. 1 indexed citations
16.
Chen, Po‐Han, Jianli Wu, Timothy J. Smith, et al.. (2019). Gigaxonin glycosylation regulates intermediate filament turnover and may impact giant axonal neuropathy etiology or treatment. JCI Insight. 5(1). 11 indexed citations
17.
Belderbos, J., et al.. (2019). Implementing the Royal College of Radiologists' Radiotherapy Target Volume Definition and Peer Review Guidelines: More Still To Do?. Clinical Oncology. 31(10). 706–710. 8 indexed citations
18.
Slevin, Finbar, Samuel Pan, Hitesh Mistry, et al.. (2019). A Multicentre UK Study of Outcomes of Nasopharyngeal Carcinoma Treated With Intensity-Modulated Radiotherapy ± Chemotherapy. Clinical Oncology. 32(4). 238–249. 8 indexed citations
20.
Chen, Po‐Han, Jianli Wu, Chien‐Kuang Cornelia Ding, et al.. (2019). Kinome screen of ferroptosis reveals a novel role of ATM in regulating iron metabolism. Cell Death and Differentiation. 27(3). 1008–1022. 225 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026